Patoulias D, Popovic DS, Stoian AP, Janez A, et al. Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: A systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trials. J Diabetes Complications 2023;37:108529.
PMID: 37301063